Cellectar biosciences announces enrollment of the first patient in pediatric high-grade gliomas phase 1b clinical study

Study of iopofosine i 131 supported by $2 million grant from the national institute of health's national cancer institute (nci) study of iopofosine i 131 supported by $2 million grant from the national institute of health's national cancer institute (nci)

CLRB Ratings Summary

CLRB Quant Ranking